Translation, innovation and enterprise
Accelerating the translation of research and driving innovation in the prevention, diagnosis and treatment of kidney disease, so that patients can benefit sooner.
Why collaborate with us?
We work with researchers and life science companies of all sizes with the one aim; research that will benefit people living with kidney disease.
We collaborate with organisations across the life science sector; pharma, biopharma, biotech and medtech to facilitate and drive new research projects.
We're members of the ABPI Patient Organisation Forum and adhere to the ABPI Code of Practice.
Ways we can support you
How we can work together to make research happen, faster.
An open door for ideas
We want to hear about new ideas and innovations that could make a difference to patients.
Tell us about your idea through our 'open door'.
Industry Partnership Programme
A programme for businesses who want to collaborate to support the development of products, treatments, therapies and diagnostics for kidney disease.
Supporting early innovation
We invest in early-stage startup propositions and companies to bridge the gap between innovative ideas and outcomes for kidney patients.
Research news
Got a question? Get in touch.
For more information or if you have any questions, get in touch with our translation, innovation and enterprise team. We're happy to talk.